Massachusetts Eye Research and Surgery Institution
1 clinical trials · Sponsor
◉ Watch Massachusetts Eye Research and Surgery Institution
| Record | Firm | Date |
|---|---|---|
| Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study (NCT06085079) | Massachusetts Eye Research and Surgery Institution | 2022-06-01 |
Track Massachusetts Eye Research and Surgery Institution automatically
Every clearance here is in the API, with alerts when new ones post.